JARID2 and prostate carcinoma: Interestingly, Juliano D. Paccez et al. identified that DHA acted as an Axl inhibitor in prostate cancer, blocking the expression of Axl through the miR-34a/miR-7/JARID2 pathway, thereby inhibiting the proliferation, migration and invasion of prostate cancer cells.